{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T15:01:29Z","timestamp":1792422089827,"version":"4.5.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,5]],"date-time":"2020-08-05T00:00:00Z","timestamp":1596585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,8,5]],"date-time":"2020-08-05T00:00:00Z","timestamp":1596585600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100008015","name":"Agria Djurf\u00f6rs\u00e4kring","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008015","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008016","name":"Svenska Kennelklubben","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008016","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Vet Scand"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>The protein chromogranin A (CgA) is stored and co-released with catecholamines from the stimulated adrenal glands. Increased plasma concentrations of CgA have been shown in people with heart disease. The aim of the study was to investigate whether plasma concentrations of the CgA-derived biologically active peptides catestatin and vasostatin were associated with the severity of myxomatous mitral valve disease (MMVD) in dogs and to assess potential associations between these blood variables and dog characteristics, echocardiographic variables, heart rate (HR), blood pressure (BP) and plasma N-terminal-proBNP (NT-proBNP) concentration. Sixty-seven privately owned dogs with or without MMVD were included. The dogs underwent physical examination, blood pressure measurement, blood sample collection, and echocardiographic examination. Plasma concentrations of catestatin and vasostatin were analyzed using radioimmunoassay.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Catestatin concentration decreased with increasing left atrial and ventricular size (R<jats:sup>2<\/jats:sup>\u2009\u2264\u20090.09, P\u2009\u2264\u20090.019), and increased with increasing systolic and diastolic blood pressures (R<jats:sup>2<\/jats:sup>\u2009\u2264\u20090.08, P\u2009\u2264\u20090.038). Regression analyses showed no significant associations for vasostatin. No differences in plasma concentrations of catestatin or vasostatin were found between the disease severity groups used in the study.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>In the present dog population, the catestatin concentration showed weak negative associations with left atrial and ventricular sizes, both of which are known to increase with increasing severity of MMVD. Furthermore, the catestatin concentration showed weak positive associations with blood pressure.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s13028-020-00541-3","type":"journal-article","created":{"date-parts":[[2020,8,5]],"date-time":"2020-08-05T11:02:58Z","timestamp":1596625378000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The chromogranin A-derived peptides catestatin and vasostatin in dogs with myxomatous mitral valve disease"],"prefix":"10.1186","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7486-0420","authenticated-orcid":false,"given":"Katja","family":"H\u00f6glund","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3402-023X","authenticated-orcid":false,"given":"Jens","family":"H\u00e4ggstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0978-836X","authenticated-orcid":false,"given":"Odd Viking","family":"H\u00f6glund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9198-4193","authenticated-orcid":false,"given":"Mats","family":"Stridsberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6277-3936","authenticated-orcid":false,"given":"Anna","family":"Tidholm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"Ljungvall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,5]]},"reference":[{"key":"541_CR1","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/215058a0","volume":"215","author":"H Blaschko","year":"1967","unstructured":"Blaschko H, Comline RS, Schneider FH, Silver M, Smith AD. Secretion of a chromaffin granule protein, chromogranin, from the adrenal gland after splanchnic stimulation. Nature. 1967;215:58\u20139.","journal-title":"Nature"},{"key":"541_CR2","doi-asserted-by":"publisher","first-page":"40C","DOI":"10.1042\/bj0970040c","volume":"97","author":"P Banks","year":"1965","unstructured":"Banks P, Helle K. The release of protein from the stimulated adrenal medulla. Biochem J. 1965;97:40C\u20131C. https:\/\/doi.org\/10.1042\/bj0970040c.","journal-title":"Biochem J"},{"key":"541_CR3","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/0167-0115(83)90145-3","volume":"6","author":"DT O\u2019Connor","year":"1983","unstructured":"O\u2019Connor DT. Chromogranin: widespread immunoreactivity in polypeptide hormone producing tissues and in serum. Regul Pept. 1983;6:263\u201380.","journal-title":"Regul Pept"},{"key":"541_CR4","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1093\/eurheartj\/ehm022","volume":"28","author":"M Pieroni","year":"2007","unstructured":"Pieroni M, Corti A, Tota B, Curnis F, Angelone T, Colombo B, et al. Myocardial production of chromogranin A in human heart: a new regulatory peptide of cardiac function. Eur Heart J. 2007;28:1117\u201327. https:\/\/doi.org\/10.1093\/eurheartj\/ehm022.","journal-title":"Eur Heart J"},{"key":"541_CR5","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s00424-017-2027-6","volume":"470","author":"KB Helle","year":"2018","unstructured":"Helle KB, Metz-Boutigue MH, Cerra MC, Angelone T. Chromogranins: from discovery to current times. Pfl\u00fcgers Arch. 2018;470:143\u201354. https:\/\/doi.org\/10.1007\/s00424-017-2027-6.","journal-title":"Pfl\u00fcgers Arch"},{"key":"541_CR6","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1093\/cvr\/cvp266","volume":"85","author":"KB Helle","year":"2010","unstructured":"Helle KB. The chromogranin A-derived peptides vasostatin-I and catestatin as regulatory peptides for cardiovascular functions. Cardiovasc Res. 2010;85:9\u201316. https:\/\/doi.org\/10.1093\/cvr\/cvp266.","journal-title":"Cardiovasc Res"},{"key":"541_CR7","first-page":"H447","volume":"245","author":"P Hjemdahl","year":"1983","unstructured":"Hjemdahl P, Linde B. Influence of circulating NE and Epi on adipose tissue vascular resistance and lipolysis in humans. Am J Physiol. 1983;245:H447\u201352.","journal-title":"Am J Physiol"},{"key":"541_CR8","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1093\/clinchem\/35.8.1631","volume":"35","author":"DT O\u2019Connor","year":"1989","unstructured":"O\u2019Connor DT, Pandlan MR, Carlton E, Cervenka JH, Hslao RJ. Rapid radioimmunoassay of circulating chromogranin A: in vitro stability, exploration of the neuroendocrine character of neoplasia, and assessment of the effects of organ failure. Clin Chem. 1989;35:1631\u20137.","journal-title":"Clin Chem"},{"key":"541_CR9","doi-asserted-by":"crossref","first-page":"3237","DOI":"10.1016\/S0021-9258(17)43286-8","volume":"259","author":"DT O\u2019Connor","year":"1984","unstructured":"O\u2019Connor DT, Frigon RP. Chromogranin A, the major catecholamine storage vesicle soluble protein. Multiple size forms, subcellular storage, and regional distribution in chromaffin and nervous tissue elucidated by radioimmunoassay. J Biol Chem. 1984;259:3237\u201347.","journal-title":"J Biol Chem"},{"key":"541_CR10","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1007\/s11897-011-0065-5","volume":"8","author":"M Yanavitski","year":"2011","unstructured":"Yanavitski M, Givertz MM. Novel biomarkers in acute heart failure. Curr Heart Fail Rep. 2011;8:206\u201311. https:\/\/doi.org\/10.1007\/s11897-011-0065-5.","journal-title":"Curr Heart Fail Rep"},{"key":"541_CR11","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1007\/s00134-012-2546-8","volume":"38","author":"H R\u00f8sj\u00f8","year":"2012","unstructured":"R\u00f8sj\u00f8 H, Nygard S, Kaukonen KM, Karlsson S, Stridsberg M, Ruokonen E, et al. Prognostic value of chromogranin A in severe sepsis: data from the FINNSEPSIS study. Intensive Care Med. 2012;38:820\u20139. https:\/\/doi.org\/10.1007\/s00134-012-2546-8.","journal-title":"Intensive Care Med"},{"key":"541_CR12","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1053\/euhj.2001.2977","volume":"23","author":"C Ceconi","year":"2002","unstructured":"Ceconi C, Ferrari R, Bachetti T, Opasich C, Volterrani M, Colombo B, et al. Chromogranin A in heart failure; a novel neurohumoral factor and a predictor for mortality. Eur Heart J. 2002;23:967\u201374. https:\/\/doi.org\/10.1053\/euhj.2001.2977.","journal-title":"Eur Heart J"},{"key":"541_CR13","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.cca.2008.10.012","volume":"400","author":"B Dieplinger","year":"2009","unstructured":"Dieplinger B, Gegenhuber A, Struck J, Poelz W, Langsteger W, Haltmayer M, et al. Chromogranin A and C-terminal endothelin-1 precursor fragment add independent prognostic information to amino-terminal proBNP in patients with acute destabilized heart failure. Clin Chim Acta. 2009;400:91\u20136. https:\/\/doi.org\/10.1016\/j.cca.2008.10.012.","journal-title":"Clin Chim Acta"},{"issue":"927","key":"541_CR14","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.ahj.2006.05.008","volume":"152","author":"ME Estensen","year":"2006","unstructured":"Estensen ME, Hognestad A, Syversen U, Squire I, Ng L, Kjekshus J, et al. Prognostic value of plasma chromogranin A levels in patients with complicated myocardial infarction. Am Heart J. 2006;152(927):e1\u20136. https:\/\/doi.org\/10.1016\/j.ahj.2006.05.008.","journal-title":"Am Heart J"},{"key":"541_CR15","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.peptides.2013.05.003","volume":"46","author":"L Liu","year":"2013","unstructured":"Liu L, Ding W, Li R, Ye X, Zhao J, Jiang J, et al. Plasma levels and diagnostic value of catestatin in patients with heart failure. Peptides. 2013;46:20\u20135. https:\/\/doi.org\/10.1016\/j.peptides.2013.05.003.","journal-title":"Peptides"},{"key":"541_CR16","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1136\/postgradmedj-2012-131060","volume":"89","author":"L Meng","year":"2013","unstructured":"Meng L, Wang J, Ding WH, Han P, Yang Y, Qi LT, et al. Plasma catestatin level in patients with acute myocardial infarction and its correlation with ventricular remodelling. Postgrad Med J. 2013;89:193\u20136. https:\/\/doi.org\/10.1136\/postgradmedj-2012-131060.","journal-title":"Postgrad Med J"},{"key":"541_CR17","doi-asserted-by":"publisher","first-page":"e0122993","DOI":"10.1371\/journal.pone.0122993","volume":"10","author":"D Zhu","year":"2015","unstructured":"Zhu D, Xie H, Wang X, Liang Y, Yu H, Gao W. Correlation of plasma catestatin level and the prognosis of patients with acute myocardial infarction. PLoS ONE. 2015;10:e0122993. https:\/\/doi.org\/10.1371\/journal.pone.0122993.","journal-title":"PLoS ONE"},{"key":"541_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8081132","author":"JA Borovac","year":"2019","unstructured":"Borovac JA, Glavas D, Susilovic Grabovac Z, Supe Domic D, D\u2019Amario D, Bozic J. Catestatin in acutely decompensated heart ailure patients: insights from the CATSTAT-HF study. J Clin Med. 2019. https:\/\/doi.org\/10.3390\/jcm8081132.","journal-title":"J Clin Med"},{"key":"541_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijcard.2016.06.065","volume":"221","author":"WQ Pan","year":"2016","unstructured":"Pan WQ, He YH, Su Q, Yang J, Fang YH, Ding FH, et al. Association of decreased serum vasostatin-2 level with ischemic chronic heart failure and with MACE in 3-year follow-up: vasostatin-2 prevents heart failure in myocardial infarction rats. Int J Cardiol. 2016;221:1\u201311. https:\/\/doi.org\/10.1016\/j.ijcard.2016.06.065.","journal-title":"Int J Cardiol"},{"key":"541_CR20","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1111\/j.1748-5827.1974.tb06529.x","volume":"15","author":"JC Whitney","year":"1974","unstructured":"Whitney JC. Observations on the effect of age on the severity of heart valve lesions in the dog. J Small Anim Pract. 1974;15:511\u201322.","journal-title":"J Small Anim Pract"},{"key":"541_CR21","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1111\/j.1749-6632.1965.tb49421.x","volume":"127","author":"DK Detweiler","year":"1965","unstructured":"Detweiler DK, Patterson DF. The prevalence and types of cardiovascular disease in dogs. Ann N Y Acad Sci. 1965;127:481\u2013516. https:\/\/doi.org\/10.1111\/j.1749-6632.1965.tb49421.x.","journal-title":"Ann N Y Acad Sci"},{"key":"541_CR22","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1892\/0891-6640(2006)20[894:hdaaco]2.0.co;2","volume":"20","author":"A Egenvall","year":"2006","unstructured":"Egenvall A, Bonnett BN, H\u00e4ggstr\u00f6m J. Heart disease as a cause of death in insured Swedish dogs younger than 10\u00a0years of age. J Vet Intern Med. 2006;20:894\u2013903. https:\/\/doi.org\/10.1892\/0891-6640(2006)20%5b894:hdaaco%5d2.0.co;2.","journal-title":"J Vet Intern Med"},{"key":"541_CR23","first-page":"75","volume":"21","author":"JW Buchanan","year":"1977","unstructured":"Buchanan JW. Chronic valvular disease (endocardiosis) in dogs. Adv Vet Sci Comp Med. 1977;21:75\u2013106.","journal-title":"Adv Vet Sci Comp Med"},{"issue":"Suppl 1","key":"541_CR24","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1748-5827.2009.00801.x","volume":"50","author":"MA Oyama","year":"2009","unstructured":"Oyama MA. Neurohormonal activation in canine degenerative mitral valve disease: implications on pathophysiology and treatment. J Small Anim Pract. 2009;50(Suppl 1):3\u201311. https:\/\/doi.org\/10.1111\/j.1748-5827.2009.00801.x.","journal-title":"J Small Anim Pract"},{"key":"541_CR25","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1016\/j.cvsm.2004.05.005","volume":"34","author":"DD Sisson","year":"2004","unstructured":"Sisson DD. Neuroendocrine evaluation of cardiac disease. Vet Clin N Am Small Anim Pract. 2004;34:1105\u201326. https:\/\/doi.org\/10.1016\/j.cvsm.2004.05.005.","journal-title":"Vet Clin N Am Small Anim Pract"},{"key":"541_CR26","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1111\/j.1939-1676.2007.tb02933.x","volume":"21","author":"ML O\u2019Sullivan","year":"2007","unstructured":"O\u2019Sullivan ML, O\u2019Grady MR, Minors SL. Plasma big endothelin-1, atrial natriuretic peptide, aldosterone, and norepinephrine concentrations in normal Doberman Pinschers and Doberman Pinschers with dilated cardiomyopathy. J Vet Intern Med. 2007;21:92\u20139.","journal-title":"J Vet Intern Med"},{"key":"541_CR27","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.2460\/javma.1990.197.11.1475","volume":"197","author":"WA Ware","year":"1990","unstructured":"Ware WA, Lund DD, Subieta AR, Schmid PG. Sympathetic activation in dogs with congestive heart failure caused by chronic mitral valve disease and dilated cardiomyopathy. J Am Vet Med Assoc. 1990;197:1475\u201381.","journal-title":"J Am Vet Med Assoc"},{"key":"541_CR28","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1186\/1756-0500-7-336","volume":"7","author":"M Stridsberg","year":"2014","unstructured":"Stridsberg M, Pettersson A, Hagman R, Westin C, H\u00f6glund O. Chromogranins can be measured in samples from cats and dogs. BMC Res Notes. 2014;7:336. https:\/\/doi.org\/10.1186\/1756-0500-7-336.","journal-title":"BMC Res Notes"},{"key":"541_CR29","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1136\/vr.152.10.293","volume":"152","author":"LH Olsen","year":"2003","unstructured":"Olsen LH, Martinussen T, Pedersen HD. Early echocardiographic predictors of myxomatous mitral valve disease in dachshunds. Vet Rec. 2003;152:293\u20137. https:\/\/doi.org\/10.1136\/vr.152.10.293.","journal-title":"Vet Rec"},{"key":"541_CR30","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1111\/jvim.12137","volume":"27","author":"I Ljungvall","year":"2013","unstructured":"Ljungvall I, H\u00f6glund K, Lillieh\u00f6\u00f6k I, Oyama MA, Tidholm A, Tvedten H, et al. Serum serotonin concentration is associated with severity of myxomatous mitral valve disease in dogs. J Vet Intern Med. 2013;27:1105\u201312. https:\/\/doi.org\/10.1111\/jvim.12137.","journal-title":"J Vet Intern Med"},{"key":"541_CR31","first-page":"311","volume-title":"Textbook of veterinary internal medicine","author":"MC Belanger","year":"2005","unstructured":"Belanger MC. Echocardiography. In: Ettinger SJ, Feldman EC, editors. Textbook of veterinary internal medicine. 6th ed. St Louis: Elsevier Saunders; 2005. p. 311\u201326.","edition":"6"},{"key":"541_CR32","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1111\/j.1740-8261.2002.tb01051.x","volume":"43","author":"K Hansson","year":"2002","unstructured":"Hansson K, H\u00e4ggstr\u00f6m J, Kvart C, Lord P. Left atrial to aortic root indices using two-dimensional and M-mode echocardiography in cavalier King Charles spaniels with and without left atrial enlargement. Vet Radiol Ultrasound. 2002;43:568\u201375.","journal-title":"Vet Radiol Ultrasound"},{"key":"541_CR33","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/j.1439-0442.1996.tb00433.x","volume":"43","author":"HD Pedersen","year":"1996","unstructured":"Pedersen HD, Kristensen B, Norby B, Lorentzen KA. Echocardiographic study of mitral valve prolapse in Dachshunds. Zentralbl Veterinarmed A. 1996;43:103\u201310.","journal-title":"Zentralbl Veterinarmed A"},{"key":"541_CR34","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1111\/j.1939-1676.2011.0774.x","volume":"25","author":"I Ljungvall","year":"2011","unstructured":"Ljungvall I, H\u00f6glund K, Carnabuci C, Tidholm A, H\u00e4ggstr\u00f6m J. Assessment of global and regional left ventricular volume and shape by real-time 3-dimensional echocardiography in dogs with myxomatous mitral valve disease. J Vet Intern Med. 2011;25:1036\u201343. https:\/\/doi.org\/10.1111\/j.1939-1676.2011.0774.x.","journal-title":"J Vet Intern Med"},{"key":"541_CR35","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.tvjl.2014.01.001","volume":"199","author":"MJ Reimann","year":"2014","unstructured":"Reimann MJ, Moller JE, Haggstrom J, Markussen B, Holen AE, Falk T, et al. R-R interval variations influence the degree of mitral regurgitation in dogs with myxomatous mitral valve disease. Vet J. 2014;199:348\u201354. https:\/\/doi.org\/10.1016\/j.tvjl.2014.01.001.","journal-title":"Vet J"},{"key":"541_CR36","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1111\/j.1939-1676.2004.tb02551.x","volume":"18","author":"CC Cornell","year":"2004","unstructured":"Cornell CC, Kittleson MD, Della Torre P, Haggstrom J, Lombard CW, Pedersen HD, et al. Allometric scaling of M-mode cardiac measurements in normal adult dogs. J Vet Intern Med. 2004;18:311\u201321.","journal-title":"J Vet Intern Med"},{"key":"541_CR37","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1677\/joe.0.1650703","volume":"165","author":"M Stridsberg","year":"2000","unstructured":"Stridsberg M, Angeletti RH, Helle KB. Characterisation of N-terminal chromogranin A and chromogranin B in mammals by region-specific radioimmunoassays and chromatographic separation methods. J Endocrinol. 2000;165:703\u201314. https:\/\/doi.org\/10.1677\/joe.0.1650703.","journal-title":"J Endocrinol"},{"key":"541_CR38","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.regpep.2003.10.023","volume":"117","author":"M Stridsberg","year":"2004","unstructured":"Stridsberg M, Eriksson B, Oberg K, Janson ET. A panel of 11 region-specific radioimmunoassays for measurements of human chromogranin A. Regul Pept. 2004;117:219\u201327. https:\/\/doi.org\/10.1016\/j.regpep.2003.10.023.","journal-title":"Regul Pept"},{"key":"541_CR39","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.tvjl.2007.12.026","volume":"180","author":"I Tarnow","year":"2009","unstructured":"Tarnow I, Olsen LH, Kvart C, H\u00f6glund K, Moesgaard SG, Kamstrup TS, et al. Predictive value of natriuretic peptides in dogs with mitral valve disease. Vet J. 2009;180:195\u2013201. https:\/\/doi.org\/10.1016\/j.tvjl.2007.12.026.","journal-title":"Vet J"},{"key":"541_CR40","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1111\/j.1939-1676.2012.00894.x","volume":"26","author":"MJ Hezzell","year":"2012","unstructured":"Hezzell MJ, Boswood A, Chang YM, Moonarmart W, Souttar K, Elliott J. The combined prognostic potential of serum high-sensitivity cardiac troponin I and N-terminal pro-B-type natriuretic peptide concentrations in dogs with degenerative mitral valve disease. J Vet Intern Med. 2012;26:302\u201311. https:\/\/doi.org\/10.1111\/j.1939-1676.2012.00894.x.","journal-title":"J Vet Intern Med"},{"key":"541_CR41","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1007\/s004240000253","volume":"439","author":"JE van Wamel","year":"2000","unstructured":"van Wamel JE, Ruwhof C, van der Valk-Kokshoorn EJ, Schrier PI, van der Laarse A. Rapid gene transcription induced by stretch in cardiac myocytes and fibroblasts and their paracrine influence on stationary myocytes and fibroblasts. Pfl\u00fcgers Arch. 2000;439:781\u20138. https:\/\/doi.org\/10.1007\/s004240000253.","journal-title":"Pfl\u00fcgers Arch"},{"key":"541_CR42","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1210\/endo.133.3.8365376","volume":"133","author":"P Mantymaa","year":"1993","unstructured":"Mantymaa P, Vuolteenaho O, Marttila M, Ruskoaho H. Atrial stretch induces rapid increase in brain natriuretic peptide but not in atrial natriuretic peptide gene expression in vitro. Endocrinology. 1993;133:1470\u20133.","journal-title":"Endocrinology"},{"key":"541_CR43","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1210\/jcem-57-5-1084","volume":"57","author":"DT O\u2019Connor","year":"1983","unstructured":"O\u2019Connor DT, Burton D, Deftos LJ. Immunoreactive human chromogranin A in diverse polypeptide hormone producing human tumors and normal endocrine tissues. J Clin Endocrinol Metab. 1983;57:1084\u20136. https:\/\/doi.org\/10.1210\/jcem-57-5-1084.","journal-title":"J Clin Endocrinol Metab"},{"key":"541_CR44","doi-asserted-by":"publisher","first-page":"E243","DOI":"10.1152\/ajpendo.1991.260.2.E243","volume":"260","author":"PE Cryer","year":"1991","unstructured":"Cryer PE, Wortsman J, Shah SD, Nowak RM, Deftos LJ. Plasma chromogranin A as a marker of sympathochromaffin activity in humans. Am J Physiol. 1991;260:E243\u20136. https:\/\/doi.org\/10.1152\/ajpendo.1991.260.2.E243.","journal-title":"Am J Physiol"},{"key":"541_CR45","first-page":"60","volume":"151","author":"RL Hamlin","year":"1967","unstructured":"Hamlin RL, Olsen I, Smith CR, Boggs S. Clinical relevancy of heart rate in the dog. J Am Vet Med Assoc. 1967;151:60\u20133.","journal-title":"J Am Vet Med Assoc"},{"key":"541_CR46","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.tvjl.2013.05.040","volume":"197","author":"AM Petit","year":"2013","unstructured":"Petit AM, Gouni V, Tissier R, Trehiou-Sechi E, Misbach C, Pouchelon JL, et al. Systolic arterial blood pressure in small-breed dogs with degenerative mitral valve disease: a prospective study of 103 cases (2007\u20132012). Vet J. 2013;197:830\u20135. https:\/\/doi.org\/10.1016\/j.tvjl.2013.05.040.","journal-title":"Vet J"},{"key":"541_CR47","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1111\/jvim.14586","volume":"30","author":"A Boswood","year":"2016","unstructured":"Boswood A, H\u00e4ggstr\u00f6m J, Gordon SG, Wess G, Stepien RL, Oyama MA, et al. Effect of pimobendan in dogs with preclinical myxomatous mitral valve disease and cardiomegaly: the EPIC Study\u2014a randomized clinical trial. J Vet Intern Med. 2016;30:1765\u201379. https:\/\/doi.org\/10.1111\/jvim.14586.","journal-title":"J Vet Intern Med"},{"key":"541_CR48","doi-asserted-by":"publisher","first-page":"691","DOI":"10.3109\/1354750X.2011.629058","volume":"16","author":"D Zhu","year":"2011","unstructured":"Zhu D, Wang F, Yu H, Mi L, Gao W. Catestatin is useful in detecting patients with stage B heart failure. Biomarkers. 2011;16:691\u20137. https:\/\/doi.org\/10.3109\/1354750X.2011.629058.","journal-title":"Biomarkers"},{"key":"541_CR49","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.2174\/0929867324666170425100416","volume":"25","author":"SK Mahata","year":"2018","unstructured":"Mahata SK, Kiranmayi M, Mahapatra NR. Catestatin: a master regulator of cardiovascular functions. Curr Med Chem. 2018;25:1352\u201374. https:\/\/doi.org\/10.2174\/0929867324666170425100416.","journal-title":"Curr Med Chem"},{"key":"541_CR50","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1111\/jvim.15331","volume":"32","author":"MJ Acierno","year":"2018","unstructured":"Acierno MJ, Brown S, Coleman AE, Jepson RE, Papich M, Stepien RL, et al. ACVIM consensus statement: guidelines for the identification, evaluation, and management of systemic hypertension in dogs and cats. J Vet Intern Med. 2018;32:1803\u201322. https:\/\/doi.org\/10.1111\/jvim.15331.","journal-title":"J Vet Intern Med"},{"key":"541_CR51","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.2460\/javma.1993.203.07.1023","volume":"203","author":"AW Beardow","year":"1993","unstructured":"Beardow AW, Buchanan JW. Chronic mitral valve disease in cavalier King Charles spaniels: 95 cases (1987\u20131991). J Am Vet Med Assoc. 1993;203:1023\u20139.","journal-title":"J Am Vet Med Assoc"}],"container-title":["Acta Veterinaria Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13028-020-00541-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13028-020-00541-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13028-020-00541-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,11]],"date-time":"2024-08-11T10:11:39Z","timestamp":1723371099000},"score":1,"resource":{"primary":{"URL":"https:\/\/actavetscand.biomedcentral.com\/articles\/10.1186\/s13028-020-00541-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,5]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["541"],"URL":"https:\/\/doi.org\/10.1186\/s13028-020-00541-3","relation":{},"ISSN":["1751-0147"],"issn-type":[{"value":"1751-0147","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,5]]},"assertion":[{"value":"6 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Local Ethical Committee in Uppsala (Approval number C12\/15), Sweden. Informed consent was obtained from each dog owner.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"43"}}